Peripheral Neuropathy Trial, Recruiting NCT07291817 Sponsor: Lo Zhiwen Joseph Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07291817
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed and dated a consent form agreeing to take part in the study
  • People who are willing to follow all study procedures and are available for the full duration of the trial
  • People who are male or female, aged between 21 and 99 years old
  • People who have been diagnosed with diabetes
  • People who have a toe blood pressure reading below 90 mmHg in the leg being treated (measured after a procedure to restore blood flow)
  • People who have an open, long-lasting wound on their foot
  • People who are able to operate the treatment device and are willing to follow the treatment plan as required by the study
  • People who are considered suitable for a treatment aimed at saving a limb affected by diabetes

Who may not be able to join:

  • People who are known to have an allergic reaction to any components of the INP device used in this trial
  • People who have taken part in another clinical trial or received an experimental treatment within the last 12 weeks before joining this study
  • People who are pregnant, or people who have a condition that significantly affects their ability to think, understand, or make decisions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lo Zhiwen Joseph
Registry
ClinicalTrials.gov
Start date
3 November 2025
Est. completion
2 November 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Change in toe arterial pressure; Change in wound surface area

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov